TASE TLVInsider-Vol 2

Page Content | Site Map

Vol. 2 | August 2009

Unsubscribe

Regulation and Innovation in Israel

When considered together, regulation and innovation would seem to be two principles with little potential for strategic overlap. read more >>

TLV Forum

Talking Regulation: IOSCO '09

International Organization of Securities Conference in Israel

view >>

TLV Interviews

Nechemia (Chemi) J. Peres

Managing General Partner & Co-Founder Pitango Venture Capital

The Israeli hi-tech sector in the world is continuing to be one of the most important global sources of innovation.

view >>

Ester Levanon

CEO The Tel Aviv Stock Exchange

I think that the fact that MSCI just upgraded Israel from emerging market to developed market is a proof of the great achievement of the Israeli economy.

view >>

Yuval Shahar

Entrepreneur

Every multinational corporation that has a technology background is constantly monitoring and looking for technology and acquisitions in Israel.

view >>

TLV Data

Israel is a place in which Investor Protection reigns supreme

Source: World Bank

Unique Human Resources

Source: Israeli Ministry of Industry, Trade & Labor

TLV Facts

TASE Market Review January-June 2009

Trading on exchanges throughout the world was characterized by high volatility but Tel Aviv Stock Exchange (TASE) shares recorded gains.

TLV Spotlight

Given Imaging: A snapshot of better health

Given Imaging has enabled a total transformation of gastrointestinal diagnostics.

Evogene, one of the world’s most established Ag-Biotech companies, leverages three extremely strong foundations that Israel is recognized for all over the world.

Kamada: A breath of innovation

Kamada produces human plasma-derived biopharmaceutical products with considerable advantages for patients.

Disclaimer:The use of this newsletter of the Tel Aviv Stock Exchange Ltd (hereinafter referred to as "the TASE") is conditional upon consent to the terms of use and privacy policy on the TASE website www.tase.co.il. By reading this newsletter and accessing the site, you are expressing your consent to these terms and conditions.

If you wish to unsubscribe from the TASE newsletter mailing list -

Please click here